Lexitas Pharma Services

Lexitas Pharma Services is a contract research organization (CRO) focused exclusively on ophthalmology. The company partners with pharmaceutical and biotechnology firms to provide specialized clinical trial services aimed at developing life-changing ophthalmic treatments. With a team of ophthalmologists, optometrists, and clinical operations specialists, Lexitas boasts over 475 years of combined experience in eye care clinical research. Lexitas offers full-service clinical trial support tailored to the unique needs of ophthalmic drug and device development. Their services encompass the entire clinical development process, from study design to study close-out. The company emphasizes a people-centric culture and collaborates closely with key opinion leaders in ophthalmology to ensure expert guidance throughout the research process. Lexitas is dedicated to helping bring new ophthalmic cures to patients through its comprehensive clinical research services.

Research Durham, United States Founded 2011 ~100 employees

Work at Lexitas Pharma Services in HR or recruiting? Claim this page

Employees
100
-1% in the 3 months to Sep 2026
12-month attrition
18%
Tech: 4.2%
H1B filings, FY2024
2
Sponsors visas
Open jobs
1
Last 30 days

Headcount trend

Lexitas Pharma Services went from 106 employees in Oct 2024 to 100 in Sep 2026. Apr to Sep 2026: 3 people joined, 3 left.

Org structure

Headcount by department

Other61
Engineering13
Operations9
Finance5
Sales5
Marketing3
HR3
Product1

H-1B sponsorship

H-1B Sponsorship Limited
H-1B Filings by Department
Engineering2

Peer reviews

Worked with someone at Lexitas Pharma Services?

Anonymous peer reviews on OffTheRecord

Read or write a review

Hiring now

Similar companies

Lexitas Pharma Services FAQ

How many employees does Lexitas Pharma Services have?

Lexitas Pharma Services has about 100 employees, down 1% over the 3 months to Sep 2026.

Does Lexitas Pharma Services sponsor H1B visas?

Yes. Lexitas Pharma Services filed 2 H1B (LCA) applications in FY2024, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.